419
Views
19
CrossRef citations to date
0
Altmetric
Review

Emerging therapeutic targets currently under investigation for the treatment of systemic amyloidosis

&
Pages 1095-1110 | Received 31 Aug 2017, Accepted 25 Oct 2017, Published online: 06 Nov 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Reina Tsuda, Koichiro Shinoda, Ryuichi Ushijima, Makiko Nakamura, Nagaaki Katoh, Johji Imura & Kazuyuki Tobe. (2021) A case of wild-type transthyretin cardiac amyloidosis with rheumatoid arthritis. Modern Rheumatology Case Reports 5:2, pages 206-213.
Read now
Marco Basset, Mario Nuvolone, Giovanni Palladini & Giampaolo Merlini. (2020) Novel challenges in the management of immunoglobulin light chain amyloidosis: from the bench to the bedside. Expert Review of Hematology 13:9, pages 1003-1015.
Read now
Filipa Bezerra, Carlos J. V. Simões, João M. Beirão, Maria João Saraiva, Rui M. M. Brito & Maria Rosário Almeida. (2019) Targeting transthyretin amyloidosis in the eye with next-generation stabilizers: AT40 displays potent TTR stabilization in the human vitreous. Amyloid 26:sup1, pages 73-74.
Read now

Articles from other publishers (16)

Marco Bonilla, Prakash Gudsoorkar, Rimda Wanchoo, Sandra M. Herrmann & Kenar D. Jhaveri. (2023) Onconephrology 2022: An Update. Kidney360 4:2, pages 258-271.
Crossref
Mario Nuvolone, Maria Girelli & Giampaolo Merlini. (2022) Oral Therapy for the Treatment of Transthyretin-Related Amyloid Cardiomyopathy. International Journal of Molecular Sciences 23:24, pages 16145.
Crossref
Rupali S. Avasare, Nicole K. Andeen, Andrea Havasi & Jonathan J. Hogan. (2021) The Clone Wars: Diagnosing and Treating Dysproteinemic Kidney Disease in the Modern Era. Journal of Clinical Medicine 10:8, pages 1633.
Crossref
Avital Angel-Korman & Andrea Havasi. (2020) Kidney Transplantation in Systemic Amyloidosis. Transplantation 104:10, pages 2035-2047.
Crossref
Alice Nevone, Giampaolo Merlini & Mario Nuvolone. (2020) Treating Protein Misfolding Diseases: Therapeutic Successes Against Systemic Amyloidoses. Frontiers in Pharmacology 11.
Crossref
Tereza Popkova, Roman Hajek & Tomas Jelinek. (2020) Monoclonal antibodies in the treatment of AL amyloidosis: co‐targetting the plasma cell clone and amyloid deposits. British Journal of Haematology 189:2, pages 228-238.
Crossref
Ridwan Babatunde Ibrahim, Ssu-Yu Yeh, Kon-Ping Lin, Frans Ricardo, Tsyr-Yan Yu, Chih-Chiang Chan, Jin-Wu Tsai & Yo-Tsen Liu. (2019) Cellular secretion and cytotoxicity of transthyretin mutant proteins underlie late-onset amyloidosis and neurodegeneration. Cellular and Molecular Life Sciences 77:7, pages 1421-1434.
Crossref
Tong-Yin Zhu, Guan-Hui Zhou, Xin-Hua Chen, Xiao-Dong Teng & Jun-Hui Sun. (2020) Hepatic veno-occlusive disease may be a rare characteristic of hepatic involvement in systemic amyloidosis: case report and literature review. Journal of International Medical Research 48:2, pages 030006052090485.
Crossref
Rahel Schwotzer, Markus Gabriel Manz, Stefanie Pederiva, Christine Waibel, Clemens Caspar, Erika Lerch, Andreas J. Flammer, Sofie Brouwers, Harald Seeger, Raphael Heimgartner, Thomas Fehr, Davide Rossi, Elena Bianchi, Georg Stüssi, Guido Ghilardi & Bernhard Gerber. (2019) Daratumumab for relapsed or refractory AL amyloidosis with high plasma cell burden. Hematological Oncology 37:5, pages 595-600.
Crossref
Ridwan Babatunde Ibrahim, Yo-Tsen Liu, Ssu-Yu Yeh & Jin-Wu Tsai. (2019) Contributions of Animal Models to the Mechanisms and Therapies of Transthyretin Amyloidosis. Frontiers in Physiology 10.
Crossref
Guoliang LiDan HanSuhua Wei, Huaiyu Wang & Limei Chen. (2019) Multiorgan involvement by amyloid light chain amyloidosis. Journal of International Medical Research 47:4, pages 1778-1786.
Crossref
Diletta Ami, Paolo Mereghetti, Andrea Foli, Masayoshi Tasaki, Paolo Milani, Mario Nuvolone, Giovanni Palladini, Giampaolo Merlini, Francesca Lavatelli & Antonino Natalello. (2019) ATR-FTIR Spectroscopy Supported by Multivariate Analysis for the Characterization of Adipose Tissue Aspirates from Patients Affected by Systemic Amyloidosis. Analytical Chemistry 91:4, pages 2894-2900.
Crossref
Mario Nuvolone & Giampaolo Merlini. (2019) Improved outcomes for kidney transplantation in AL amyloidosis: impact on practice. Kidney International 95:2, pages 258-260.
Crossref
Mario Nuvolone, Paolo Milani, Giovanni Palladini & Giampaolo Merlini. (2018) Management of the elderly patient with AL amyloidosis. European Journal of Internal Medicine 58, pages 48-56.
Crossref
Nisha S. Joseph & Jonathan L. Kaufman. (2018) Novel Approaches for the Management of AL Amyloidosis. Current Hematologic Malignancy Reports 13:3, pages 212-219.
Crossref
Gareth J. Morgan, Grace A. Usher & Jeffery W. Kelly. (2017) Incomplete Refolding of Antibody Light Chains to Non-Native, Protease-Sensitive Conformations Leads to Aggregation: A Mechanism of Amyloidogenesis in Patients?. Biochemistry 56:50, pages 6597-6614.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.